Nanotech Could Transform Organ Transplants

Sign up for AABME’s white paper series to receive the next white paper authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott.

October 18, 2017

The growing organ shortage costs tens of thousands of lives and billions of dollars in healthcare expenditures each year, according to a recent roadmap from the Organ Preservation Alliance. In previous efforts, nanotechnology has been identified as a key platform that can lead to advances in organ banking and transplantation. In this whitepaper, find out how nanotechnology is poised to play a pivotal role in organ preservation and transplantation in the coming years.

Sign up for AABME’s white paper series to receive Nanotechnology’s Potential To Transform Organ Transplantation authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott, on behalf of the Organ Preservation Alliance. 

Related Content

WEBINAR SERIES: 3D Printing at the Point of Care

AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer
WEBINAR: Simplifying Quality Systems for Tissue Engineering Success: Lessons from the Nuclear Power Industry

In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.
WEBINAR: Virtual Reality: A Brief Review of the Future

This presentation will provide a brief description of the various forms of VR technology and describe the trajectory of Clinical VR over the last 20 years addressing health and clinical treatment of anxiety disorders, PTSD, pain management, autism, and in the assessment/rehabilitation of stroke, brain injury, and other neurologically-based conditions. We will also discuss advances in Virtual Human technology for clinical training, healthcare coaching, and clinical interviewing.

Browse similar articles

WEBINAR SERIES: 3D Printing at the Point of Care

AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer

View Now

WEBINAR: Simplifying Quality Systems for Tissue Engineering Success: Lessons from the Nuclear Power Industry

In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.

View Now